51 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Genesis Research LLC's own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
Frequent amendments usually mean worksite or role changes; each one must be covered by a new LCA before the change takes effect.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 3% above the DOL prevailing wage across 20 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Genesis Research LLC sponsors H-1B workers, with 51 certified LCAs on file (FY2021–FY2026), including 9 in FY2026. The median certified salary is $130,000 (P25 $123,799, P75 $146,400). 100% of its certified filings meet or exceed the prevailing wage.
Genesis Research LLC H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 71% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 5 | 0 | 0 | 5 |
| FY2022 | 13 | 0 | 0 | 13 |
| FY2023 | 13 | 0 | 0 | 13 |
| FY2024 | 3 | 0 | 0 | 3 |
| FY2025 | 8 | 0 | 0 | 8 |
| FY2026 | 9 | 0 | 0 | 9 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Principal Scientist, Analytics I-200-26152-967840 | $151,325/yr | IV | Jersey City, NJ | Jun 01, 2026 | Certified |
Senior Scientist, Dashboard and Analytics I-200-26149-964246 | $123,998/yr | II | Hoboken, NJ | May 29, 2026 | Certified |
Scientist, Eipdemiology I-200-26149-961617 | $146,464/yr | IV | Washington, Dc, DC | May 29, 2026 | Certified |
Scientist, Analytics I-200-26134-910895 | $115,407/yr | III | Los Angeles, CA | May 14, 2026 | Certified |
Scientist, Analytics I-200-26113-827313 | $115,407/yr | III | Los Angeles, CA | Apr 23, 2026 | Certified |
Senior Scientist, Analytics I-200-26113-827318 | $125,821/yr | IV | Bayonne, NJ | Apr 23, 2026 | Certified |
Scientist, Epidemiology I-200-26107-807139 | $125,000/yr | IV | Cedar Park, TX | Apr 17, 2026 | Certified |
Senior Scientist, Analytics I-200-26107-807124 | $123,600/yr | IV | New Brunswick, NJ | Apr 17, 2026 | Certified |
Scientist, Epidemiology I-200-26107-807146 | $123,600/yr | IV | Jersey City, NJ | Apr 17, 2026 | Certified |
Director, Analytics I-200-25234-262584 | $185,100/yr | IV | Foster City, CA | Aug 22, 2025 | Certified |
Senior Scientist, Epidemiology I-200-25150-037244 | $135,002/yr | IV | North Brunswick, NJ | May 30, 2025 | Certified |
Senior Scientist, Biostatistics I-200-25150-037303 | $142,258/yr | IV | Waltham, MA | May 30, 2025 | Certified |
Senior Scientist, Epidemiology I-200-25148-025662 | $142,258/yr | IV | North Brunswick, NJ | May 28, 2025 | Certified |
Senior Scientist, Epidemiology I-200-25148-025969 | $135,002/yr | IV | Waltham, MA | May 28, 2025 | Certified |
Senior Scientist, Analytics I-200-25148-025970 | $124,352/yr | IV | Philadelphia, PA | May 28, 2025 | Certified |
Senior Scientist, Dashboards and Analytics I-200-25142-006569 | $123,998/yr | IV | Nashville, TN | May 22, 2025 | Certified |
Senior Scientist, Analytics I-200-24344-527893 | $124,740/yr | IV | Glendale, CA | Dec 09, 2024 | Certified |
Senior Scientist, Dashboards & Analytics I-200-24151-050716 | $108,770/yr | II | Hoboken, NJ | May 30, 2024 | Certified |
Senior Scientist, Dashboards & Analytics I-200-24143-023358 | $108,770/yr | II | Hoboken, NJ | May 22, 2024 | Certified |
Client Analytics Scientist I-200-24113-912214 | $120,893/yr | II | Thousand Oaks, CA | Apr 22, 2024 | Certified |
Scientist, Epidemiology I-200-23234-285216 | $120,739/yr | II | Washington, Dc, DC | Aug 22, 2023 | Certified |
Senior Scientist, RWE Analytics I-200-23234-285097 | $129,600/yr | II | Jersey City, NJ | Aug 22, 2023 | Certified |
Scientist, RWE Analytics I-200-23234-285123 | $108,063/yr | II | Cambridge, MA | Aug 22, 2023 | Certified |
Scientist, RWE Analytics I-200-23234-285150 | $126,099/yr | II | Oklahoma City, OK | Aug 22, 2023 | Certified |
Sr. Manager, Evid. Strategy (Pharmaceutical & Biostatistics) I-200-23116-967755 | $145,000/yr | IV | Hoboken, NJ | Apr 26, 2023 | Certified |
Director, Evidence Strategy I-200-23116-967757 | $187,460/yr | IV | Hoboken, NJ | Apr 26, 2023 | Certified |
Analytical Team Lead, Real Wld Evid. Analyt. (Biostatistics) I-200-23032-742288 | $146,400/yr | III | Hoboken, NJ | Feb 01, 2023 | Certified |
Princ. Scientist, Biostatistics (Real World Evid. Analytics) I-200-23020-716866 | $146,400/yr | III | Hoboken, NJ | Jan 20, 2023 | Certified |
Princ. Scientist, Biostatistics (Real World Evid. Analytics) I-200-23005-683939 | $146,400/yr | III | Hoboken, NJ | Jan 05, 2023 | Certified |
Senior Scientist (Epidemiologist) I-200-22356-657000 | $145,000/yr | III | Hoboken, NJ | Dec 22, 2022 | Certified |
Director, Business Development (Biotechnology) I-200-22350-644948 | $170,000/yr | IV | Hoboken, NJ | Dec 16, 2022 | Certified |
Executive Director, Evidence Strategy I-200-22257-472960 | $236,300/yr | IV | Hoboken, NJ | Sep 14, 2022 | Certified |
Associate Director, Evidence and Data Science Strategy I-200-22244-451195 | $170,000/yr | IV | Hoboken, NJ | Sep 01, 2022 | Certified |
Associate Director, Evidence and Data Science Strategy I-200-22243-448635 | $170,000/yr | IV | Hoboken, NJ | Aug 31, 2022 | Certified |
Associate Director, Evidence and Data Science Strategy I-200-22225-415181 | $170,000/yr | IV | Hoboken, NJ | Aug 13, 2022 | Certified |
Senior Scientist I-200-22206-373176 | $132,000/yr | II | Hoboken, NJ | Jul 25, 2022 | Certified |
Epidemiologist (Real World Data & Advanced Analytics) I-200-22132-165001 | $115,000/yr | II | Hoboken, NJ | May 12, 2022 | Certified |
Senior Scientist, RWE-A I-200-22132-164925 | $125,000/yr | III | Hoboken, NJ | May 12, 2022 | Certified |
Epidemiologist (Real World Data & Advanced Analytics) I-200-22132-165004 | $145,000/yr | III | Hoboken, NJ | May 12, 2022 | Certified |
Epidemiologist (Real World Data & Advanced Analytics) I-200-22131-157804 | $115,000/yr | II | Hoboken, NJ | May 10, 2022 | Certified |
Epidemiologist (Real World Data & Advanced Analytics) I-200-22131-157764 | $145,000/yr | III | Hoboken, NJ | May 10, 2022 | Certified |
Senior Scientist, RWE-A I-200-22124-135722 | $125,000/yr | III | Hoboken, NJ | May 04, 2022 | Certified |
Senior Biostatistics Analyst(Real World Data&Adv.Analytics) I-200-22020-842640 | $130,000/yr | IV | Pasadena, CA | Jan 20, 2022 | Certified |
Scientist, Public Health Evidence Analytics I-200-21355-780214 | $110,000/yr | III | Los Angeles, CA | Dec 21, 2021 | Certified |
Software Developer, Data Visualization I-200-21125-289411 | $79,000/yr | I | Hoboken, NJ | May 05, 2021 | Certified |
Assoc. Dir., Evidence Strategy in Pharmacy & Health Outcomes I-200-21099-213522 | $150,000/yr | IV | Hoboken, NJ | Apr 09, 2021 | Certified |
Real World Evidence Scientist/ Statistics I-200-20318-911612 | $130,000/yr | II | Hoboken, NJ | Nov 13, 2020 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: May and Apr — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
8 states · 17 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →